Wealthfront Advisers’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $521K | Sell |
18,887
-12,131
| -39% | -$335K | ﹤0.01% | 786 |
|
|
2025
Q1 | $879K | Buy |
31,018
+18,268
| +143% | +$518K | ﹤0.01% | 684 |
|
|
2024
Q4 | $530K | Sell |
12,750
-161
| -1% | -$6.69K | ﹤0.01% | 771 |
|
|
2024
Q3 | $863K | Sell |
12,911
-9,172
| -42% | -$613K | ﹤0.01% | 672 |
|
|
2024
Q2 | $2.62M | Buy |
22,083
+8,081
| +58% | +$960K | 0.01% | 419 |
|
|
2024
Q1 | $1.49M | Buy |
14,002
+9,003
| +180% | +$959K | 0.01% | 539 |
|
|
2023
Q4 | $497K | Buy |
+4,999
| New | +$497K | ﹤0.01% | 719 |
|
|
2023
Q2 | – | Sell |
-16,804
| Closed | -$2.58M | – | 836 |
|
|
2023
Q1 | $2.58M | Sell |
16,804
-8,005
| -32% | -$1.23M | 0.01% | 358 |
|
|
2022
Q4 | $4.46M | Buy |
24,809
+15,666
| +171% | +$2.81M | 0.02% | 223 |
|
|
2022
Q3 | $1.08M | Sell |
9,143
-6,162
| -40% | -$729K | 0.01% | 473 |
|
|
2022
Q2 | $2.19M | Sell |
15,305
-12,877
| -46% | -$1.84M | 0.01% | 357 |
|
|
2022
Q1 | $4.86M | Sell |
28,182
-5,519
| -16% | -$951K | 0.02% | 213 |
|
|
2021
Q4 | $8.56M | Buy |
33,701
+3,815
| +13% | +$969K | 0.04% | 117 |
|
|
2021
Q3 | $11.5M | Buy |
29,886
+24,157
| +422% | +$9.3M | 0.05% | 73 |
|
|
2021
Q2 | $1.35M | Buy |
+5,729
| New | +$1.35M | 0.01% | 382 |
|